ITPR1 and neoplasm: Our study suggested that TAMs-CM treatment inactivated IP3R, which not only increased expression of GRP78 but also kept low calcium levels in mitochondrial and maintained mitochondrial bioenergetics, thereby facilitating tumor progress.